Medical Treatments
Articles tagged with Medical Treatments
Recognizing and managing IEC-HS: A life-threatening complication of CAR-T therapy
Short-term and late-term effects of psilocybin on symptoms in major depression
American Society for Radiation Oncology (ASTRO) to host Annual Meeting in Boston, September 26-30
The 1st annual meeting on experimental therapeutics
Rhein attenuates severe acute pancreatitis-associated intestinal injury through pparγ regulating macrophage activation
Preoperative VR exposure studied in surgical care at Semmelweis University’s Pediatric Center
A simple X-ray measure linked to survival in lung cancer surgery patients
Antibody spurs nerve fiber regrowth following spinal cord injury
A novel antibody, NG101, accelerates the regeneration of damaged spinal cord tissue by neutralizing a protein that blocks nerve fiber growth. This therapy enables new nerve fibers to form functional connections, allowing patients to become more independent and potentially recover arm and hand function.
Toloo Taghian awarded $3.2M to develop gene therapy for a rare genetic disease
Sleep habits may raise dementia risk — and researchers are closer to understanding how
New JACIE IEC Certification pathway opens the door for centers beyond transplant
The new certification framework covers the full IEC therapy process, including patient selection, clinical care, and post-infusion monitoring. It emphasizes critical aspects unique to IEC therapies, such as chain-of-identity and recognition of therapy-specific toxicities.
New Chinese Neurosurgical Journal study report novel surgical strategy for moyamoya disease
Researchers develop tailored revascularization approach for moyamoya disease, improving circulation while minimizing complications. The technique, called STAPC, uses vessel diameter, blood-flow dynamics, and recipient brain arteries to guide surgical decisions.
Kumamoto University Professor Emeritus Eiichi Araki awarded Medal of Honor with Purple Ribbon for landmark discoveries in diabetes research
Professor Eiichi Araki's pioneering research on insulin signaling has led to a deeper understanding of the molecular mechanisms of diabetes. His discoveries remain foundational for researchers striving to overcome insulin resistance and improve treatment options.
Efficacy and safety of digitalis glycosides in heart failure
Digoxin in patients with symptomatic rheumatic heart disease
Intravenous tenecteplase prior to endovascular treatment for ischemic stroke at 4.5 to 24 hours
Edible cannabis and pain, sleep, and mental health management in older adults
Cost-effectiveness of the START hospital addiction consultation service for opioid use disorder treatment
Scientists finally see inside the ‘black box’ of depression treatment
Psilocybin in the treatment of cocaine use disorder
Ketamine infusions and rapid reduction of suicidal and depressive symptoms in major depressive episode
A systematic review and meta-analysis found single and repeated intravenous ketamine infusions to be efficacious in reducing suicidal and depressive symptoms in acute major depressive episodes. Longer-term outcomes remain unclear.
A new mechanism regulating beta cell mass under stress
Researchers at Kyoto University discovered that ATF6α plays a critical role in enabling the survival and proliferation of beta cells under sustained stress, leading to impaired beta cell mass expansion. The study highlights the potential for developing new therapeutic strategies to preserve and restore beta cell mass in diabetes.
Lesions as a window into cause: a psychiatrist bets that circuits, not regions, explain psychiatric disorders
Gonçalo Cotovio uses lesion network mapping to identify the circuits responsible for psychiatric symptoms, aiming to develop personalized brain stimulation treatments. His work has produced striking findings in mania and obsessive-compulsive disorder, with ambitions to extend to disordered feeding behavior.
Treatment of anxiety for adults in primary care settings
The American Medical Association (AMA) has developed guidelines for treating anxiety disorders in adults in primary care settings. Behavioral therapy, including cognitive-behavioral therapy (CBT), and medication, such as selective serotonin reuptake inhibitors (SSRIs), are recommended treatments.
I’m concerned about anxiety—what do I need to know?
This article provides an overview of anxiety disorders, including their symptoms, diagnosis, and treatment options. The study found that anxiety disorders can be effectively managed with a combination of therapy and medication.
Chinese Medical Journal article review highlights a growing global consensus on acute-on-chronic liver failure
Researchers agree on core elements of ACLF development, including chronic liver disease triggers, acute insult, and extrahepatic organ failure. A new three-stage mouse model supports testing of potential therapies, highlighting impaired liver regeneration as a key driver of disease progression.
New study finds link between difficulty identifying emotions and higher chronic pain levels
A large study found that individuals with difficulty recognizing and expressing emotions experience greater disruption to daily life from pain over time due to increased psychological distress. The study also suggests that addressing emotional processing difficulties may be key to improving long-term outcomes for people with chronic pain.
Phage therapy at a turning point: Valencia 2026 to define the next era of antibacterial medicine
The Targeting Phage Therapy 2026 Congress will bring together experts to address clinical, regulatory, industrial, and hospital infrastructure requirements for phage therapy. The congress aims to move phage therapy from promising science to accessible, validated, and deployable medicine.
Researcher awarded $2.75M NIH grant to develop next-gen cancer treatments
Binghamton University Professor L. Nathan Tumey is working on developing new chemical technologies for antibody-drug-conjugates to push the boundaries of what can be accomplished in ADCs. The goal is to awaken tumor-associated immune cells and prevent cancer regrowth.
USC and Tempus form strategic collaboration aimed at accelerating innovation across research and patient care
The Keck School of Medicine of USC and Tempus are creating a system-wide framework to integrate clinical care, clinical trials, and research through AI-powered precision medicine tools. The goal is to enhance patient care and accelerate research and innovation.
Disparities in disease presentation and treatment initiation for de novo metastatic breast cancer
A cross-sectional study of patients with de novo metastatic breast cancer found racial and ethnic disparities in disease presentation. De novo metastatic breast cancer disproportionately contributes to breast cancer mortality in the U.S., emphasizing the need for tailored interventions to improve care delivery and outcomes.
USC-led team receives funding to build next-generation medical device that uses tears to monitor health
A USC-led team is working on a medical device that uses tears to monitor health, starting with dry eye disease. The device aims to provide continuous monitoring and automated medication delivery, improving patient comfort and treatment efficacy.
Millions suffering needlessly with curable hepatitis C, new analysis reveals
A new analysis found that prescriptions for curable hepatitis C drugs have declined sharply in recent years, leaving millions without treatment. The researchers urge swift actions to deliver the drugs to those who need them, including increased screening and system-level changes.
Alliance study shows new promise against locally advanced lung cancer
A study by the Alliance Foundation Trials shows that combining immunotherapy and chemotherapy before surgery can help more patients with locally advanced non-small cell lung cancer undergo complete cancer resection, improving their long-term health. The treatment also led to high rates of lymph node clearance and successful surgical re...
Rare scalp reaction identified in lung cancer patient receiving amivantamab after radiotherapy
A rare scalp reaction resembling erosive pustular dermatosis was identified in a lung cancer patient treated with amivantamab following cranial radiotherapy. The reaction appeared to be related to impaired wound healing due to dual inhibition of EGFR and MET signaling pathways.
Point-of-care hepatitis C testing in a tribal setting
A community-based point-of-care HCV RNA testing program was feasible and led to a high percentage of same-day treatment for American Indian and Alaska Native participants. The study supports expanding point-of-care HCV RNA testing and integrated treatment to advance HCV elimination.
RBL LLC launches Duracyte, advancing living pharmacy platform in Houston’s growing biotech hub
Duracyte's technology uses an implantable device to produce therapeutic proteins continuously inside the human body, replacing injections and infusions with a single device. The device can sense biological signals, monitor tumor environments and adjust therapeutic output in real time.
Surface charge and membrane lipid composition define extracellular vesicle (EV) function: Lipid asymmetry enables new quality metrics for EV-based therapeutics
A comprehensive review reveals how phospholipid asymmetry governs EV surface charge, providing a unified framework for classification, functional understanding, and standardization in nanomedicine. The study highlights the importance of membrane lipid composition and surface charge in determining EV function.
Scientists reverse brain aging, with a nasal spray
Researchers developed a nasal spray that reversibly reduces brain inflammation, restores cellular power plants, and improves memory. The treatment bypasses the brain's protective shield through intranasal delivery, suppressing chronic inflammation and promoting successful brain aging.
New study reveals why some Chinese immigrants in the US may turn to China-based telehealth apps
A recent study found that 15% of Chinese immigrants use China-based telehealth apps for medical advice while living in the US. These apps are preferred due to lower costs, ease of access, and language support. However, reliance on foreign-based services raises concerns about patient safety, continuity of care, and regulatory oversight.
Anatomy & Innovation Center for Education and Research inaugurated at Semmelweis University
The center offers state-of-the-art facilities for practical skills acquisition, digital technologies integration, and innovation in medical procedures. Future physicians will benefit from cadaver training, real-time imaging, and collaborative research opportunities.
Penn researchers use AI to surface unreported GLP-1 side effects in Reddit posts
Researchers identified patient-reported symptoms associated with GLP-1s, including menstrual changes, fatigue, and temperature-related complaints, that may not be fully captured in clinical trials or drug labeling. Nearly 4% of Reddit users reported reproductive symptoms, and fatigue was the second most common complaint.
Role of environmental enrichment in poststroke functional recovery
A new study shows that poststroke environmental enrichment reduces chronic inflammation and promotes sustained sensorimotor recovery in mice. The study found that enriched environment mice had better neurological scores and stronger recovery compared to standard environment mice.
New AI technology to speed drug development
Scientists at the University of Virginia Health System have developed a suite of AI-powered tools, called YuelDesign, YuelPocket and YuelBond, to transform how new drugs are created. These tools can design drug molecules tailored to fit their protein targets exactly, even accounting for protein flexibility.
Without the right tests, the best medicines make no difference
A new analysis from UC San Francisco argues that diagnostics are being overlooked, slowing progress against major diseases despite advances in targeted therapies. The study suggests that nearly half of the world's population lacks adequate access to diagnostics due to inadequate investment and insurance reimbursement.
Antidepressant unable to prevent chemotherapy-associated nerve damage
A randomized trial found that duloxetine does not prevent painful neuropathy caused by oxaliplatin-based chemotherapy in patients with stage II or III colorectal cancer. The study suggests that duloxetine should only be used for managing existing neuropathy, not prevention.
Scientists reverse severe epilepsy in lab mice in promising step toward a cure
Researchers used base editing to correct the SCN8A gene mutation responsible for severe inherited epilepsy. The approach successfully eliminated or reduced seizures and improved brain function in lab mice, offering new hope for treating genetic epilepsies.
Adjuvant PD-1/PD-L1 inhibitors show efficacy but highlight safety considerations in solid cancers
The study found that immune checkpoint inhibitors significantly improved key clinical outcomes, including disease-free survival and distant metastasis-free survival. However, no clear improvement in overall survival was observed across studies, highlighting the need for careful patient selection and monitoring.
Are we seeing changes in the rates of secondary blood-related cancers that develop due to chemotherapy or radiation?
A study from Japan has revealed a gradual increase in tAML rates, especially after breast cancer treatment. The study analyzed data from the Osaka Cancer Registry and found that the annual incidence of tAML increased from 0.13 to 0.36 per 100,000 population between 1990 and 2020.
Setting standards of care for brain injuries in first responders
Researchers at Ohio State University developed the first evidence-based guidelines for traumatic brain injury recognition and management in first responders. The guidelines aim to improve care and support for law enforcement officers, firefighters, and others who risk head injuries on the job.
New study finds interferon therapy to be well-tolerated in compensated hepatitis B cirrhosis
A multicenter analysis of 920 patients with compensated cirrhosis found that interferon therapy was not associated with a higher risk of serious complications compared to standard treatment. Milder side effects were more common and required closer monitoring.
Alliance marks Adolescent and Young Adult Cancer Awareness Week
The Alliance for Clinical Trials in Oncology is enrolling adolescent and young adult cancer patients in various trials, including genetic services and treatment studies. These trials aim to address longstanding gaps in care and improve outcomes for AYAs with cancer.
Blood purification beyond dialysis
The oXiris membrane addresses complex sepsis by integrating diffusion, convection, and adsorptive properties to remove inflammatory mediators. Early physiological improvements and potential benefits for cardiac surgery-associated acute kidney injury and severe COVID-19 have been reported in observational studies.
Unmasking a hidden driver of glioma: CHKA teams up with EGFR to ignite the MAPK pathway
A study reveals CHKA and EGFR cooperate to activate the MAPK pathway, driving glioma progression. CHKA knockdown suppresses tumor growth, while EGFR overexpression rescues this effect.
ASH publishes clinical practice guidelines on diagnosis and management of severe and very severe acquired aplastic anemia
The American Society of Hematology has published clinical practice guidelines for diagnosing and managing severe acquired aplastic anemia, a rare and life-threatening bone marrow failure disorder. The guidelines highlight the importance of shared decision-making between patients and providers, as well as the need for additional researc...
Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer
A phase 1/2 clinical study found that pralsetinib improved durable responses with manageable safety profiles in patients with advanced or metastatic RET fusion-positive non-small cell lung cancer. The overall response rate was 78% and median duration of response was longer in patients with the CCDC6-RET fusion gene.
Postacute sequelae following omicron COVID-19 in patients with cancer
Among highly boosted patients with cancer, overall postacute sequelae risk was not elevated compared to noninfected patients; hospitalized COVID-19 patients remained at increased risk despite therapeutics. Vaccination and boosting remain important in mitigating long COVID among immunocompromised patients
Cancer treatment: Understanding risks and side effects
Researchers used machine learning methods to identify safe time windows for outpatient stem cell therapy in multiple myeloma patients. The study found that this approach can predict adverse events and enable more precise risk assessment.
Wendy Thompson named recipient of the 2026 IADR Distinguished Scientist Award in Pharmacology/Therapeutics/Toxicology Research
Wendy Thompson, a Senior Clinical Lecturer at the University of Manchester, has been awarded the IADR Distinguished Scientist Award in Pharmacology/Therapeutics/Toxicology Research. Her research focus on antimicrobial stewardship and primary dental care has made significant contributions to the field.